MOLLY REGAN: Open Payments
NPI 1932559242 · MANCHESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 20 payments from 9 companies in 2025. Trend: 2023 $741 · 2024 $610 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $127 |
| Novo Nordisk Inc | 2 | $122 |
| PFIZER INC. | 4 | $84 |
| ABBVIE INC. | 4 | $83 |
| Exact Sciences Corporation | 3 | $66 |
| Lilly USA, LLC | 2 | $45 |
| Indivior Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $19 |
Products named: Wegovy, PREVNAR 20, VRAYLAR, The Cologuard Plus Collection Kit, SUBLOCADE, ZEPBOUND, AREXVY, MOUNJARO.
Industry payments across MA — which companies pay providers there.
